SILO PHARMA INC (SILO) Stock Income Statement
NASDAQ:SILO - Nasdaq - US82711P2011 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 72.00K | 72.10K | 72.10K | 70.00K | 70.00K | |||
| Cost Of Goods | 6.00K | 5.80K | 5.80K | 10.00K | 10.00K | |||
| Gross Profit | 66.40K | 66.30K | 66.30K | 70.00K | 70.00K | |||
| Operating Expenses | 4.99M | 4.77M | 3.92M | 3.69M | 2.81M | |||
| Research and Development | 2.58M | 2.37M | 845.10K | 1.29M | 690.00K | |||
| Selling, General, and Administrative Expenses | 2.47M | 2.40M | 3.08M | 2.41M | 2.12M | |||
| Operating Income | -4.92M | -4.71M | -3.86M | -3.63M | -2.75M | |||
| Interest Income/Expense | 297.60K | 312.80K | 390.50K | -370.00K | 6.91M | |||
| Other Income/Expense | N/A | N/A | -166.00K | 90.00K | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 20.00K | |||
| Income Before Taxes | -4.62M | -4.39M | -3.63M | -3.91M | 4.18M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 20.00K | |||
| Net Income | -4.62M | -4.39M | -3.70M | -3.91M | 2.50M | |||
| EBITDA | N/A | -4.70M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.14 | -1.19 | -1.20 | -1.71 | 1.30 | |||
| Statistics | ||||||||
| Gross Profit Margin | 92.22% | 91.96% | 91.96% | 100.00% | 100.00% | |||
| Profit Margin | -6420.28% | -6092.79% | -5132.73% | -5585.71% | 3571.43% | |||
| Operating Profit Margin | -6833.75% | -6526.63% | -5347.57% | -5185.71% | -3928.57% | |||
All data in USD